tiprankstipranks
Grace Therapeutics (GRCE)
NASDAQ:GRCE
US Market
GRCE
Grace Therapeutics
RESEARCH TOOLSreports
Want to see GRCE full AI Analyst Report?

Grace Therapeutics (GRCE) Income Statement

1,204 Followers

Grace Therapeutics Income Statement

Last quarter (Q3 2026), Grace Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Grace Therapeutics's net income was C$-3.18M. See Grace Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 196.00K
Gross Profit
C$ 0.00C$ -11.00KC$ 0.00C$ 0.00C$ 120.00K
Operating Expenses
C$ 16.68MC$ 11.30MC$ 52.16MC$ 15.59MC$ 16.54M
Depreciation and Amortization
C$ 7.00KC$ 11.00KC$ 124.00KC$ 0.00C$ 924.00K
EBITDA
C$ -16.67MC$ -14.62MC$ -18.12MC$ -15.34MC$ -9.79M
Operating Income
C$ -16.68MC$ -11.31MC$ -52.16MC$ -15.59MC$ -16.42M
Other Income/Expenses
C$ 3.91MC$ -3.32MC$ 184.00KC$ 5.12MC$ -3.26M
Pretax Income
C$ -12.77MC$ -14.63MC$ -51.97MC$ -10.47MC$ -19.68M
Net Income
C$ -9.57MC$ -12.85MC$ -42.43MC$ -9.82MC$ -19.68M
Per Share Metrics
Basic EPS
C$ -0.79C$ -1.73C$ -5.71C$ -1.60C$ -7.98
Diluted EPS
C$ -0.79C$ -1.73C$ -5.71C$ -1.60C$ -7.98
Weighted Average Shares Outstanding
 12.09M 7.44M 7.43M 6.14M 2.47M
Weighted Average Shares Outstanding (Diluted)
 12.09M 7.44M 7.43M 6.14M 2.47M
Currency in CAD

Grace Therapeutics Earnings and Revenue History